Compare AXGN & DHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXGN | DHC |
|---|---|---|
| Founded | N/A | 1998 |
| Country | United States | United States |
| Employees | 452 | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.1B |
| IPO Year | N/A | N/A |
| Metric | AXGN | DHC |
|---|---|---|
| Price | $30.58 | $5.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $33.67 | $5.75 |
| AVG Volume (30 Days) | 922.8K | ★ 935.5K |
| Earning Date | 10-29-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 0.82% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $214,709,000.00 | ★ $1,537,901,000.00 |
| Revenue This Year | $21.60 | $4.79 |
| Revenue Next Year | $15.83 | $3.64 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 18.72 | 4.10 |
| 52 Week Low | $9.22 | $2.00 |
| 52 Week High | $34.24 | $5.16 |
| Indicator | AXGN | DHC |
|---|---|---|
| Relative Strength Index (RSI) | 51.59 | 58.42 |
| Support Level | $32.03 | $4.62 |
| Resistance Level | $33.84 | $5.15 |
| Average True Range (ATR) | 1.39 | 0.16 |
| MACD | -0.32 | -0.02 |
| Stochastic Oscillator | 32.41 | 75.47 |
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs. Majority of revenue is from SHOP segment.